Cellectis SA (CLLS)
2.52
-0.10
(-3.81%)
USD |
NASDAQ |
Apr 24, 16:00
2.52
0.00 (0.00%)
After-Hours: 20:00
Cellectis Cash from Operations (TTM): -65.68M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -65.68M |
| June 30, 2023 | -74.63M |
| March 31, 2023 | -79.16M |
| December 31, 2022 | -87.44M |
| September 30, 2022 | -107.31M |
| June 30, 2022 | -111.69M |
| March 31, 2022 | -100.24M |
| December 31, 2021 | -104.56M |
| September 30, 2021 | -117.37M |
| June 30, 2021 | -112.55M |
| March 31, 2021 | -122.65M |
| December 31, 2020 | -80.26M |
| September 30, 2020 | -49.26M |
| June 30, 2020 | -46.30M |
| March 31, 2020 | -45.29M |
| December 31, 2019 | -69.14M |
| Date | Value |
|---|---|
| September 30, 2019 | -86.86M |
| June 30, 2019 | -79.23M |
| March 31, 2019 | -70.56M |
| December 31, 2018 | -68.14M |
| September 30, 2018 | -57.05M |
| June 30, 2018 | -57.53M |
| March 31, 2018 | -56.03M |
| December 31, 2017 | -52.33M |
| September 30, 2017 | -41.15M |
| June 30, 2017 | -27.66M |
| March 31, 2017 | -26.78M |
| December 31, 2016 | -32.71M |
| September 30, 2016 | -6.048M |
| June 30, 2016 | -9.276M |
| March 31, 2016 | -17.29M |
| December 31, 2015 | 3.591M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-122.65M
Minimum
Mar 2021
-45.29M
Maximum
Mar 2020
-85.53M
Average
-83.56M
Median
Cash from Operations (TTM) Benchmarks
| DBV Technologies SA | -79.65M |
| Biophytis SA | -13.97M |
| Genfit SA | -- |
| Edap TMS SA | -15.89M |
| Biodexa Pharmaceuticals Plc | -8.515M |